RSS-Feed abonnieren
DOI: 10.1055/s-2000-13446
FUNCTIONAL RESIDUAL CAPACITY AND STATIC COMPLIANCE DURING THE FIRST YEAR IN PRETERM INFANTS TREATED WITH SURFACTANT
Publikationsverlauf
Publikationsdatum:
31. Dezember 2000 (online)
![](https://www.thieme-connect.de/media/ajp/200007/lookinside/thumbnails/10.1055-s-2000-13446-1.jpg)
ABSTRACT
Individual lung development during the first year of life was studied in surfactant treated preterm infants with respiratory distress syndrome (RDS) and healthy controls, as well as in a group who subsequently developed chronic lung disease of the newborn (CLDN). Lung development was assessed from functional residual capacity (FRC) and compliance of the respiratory system (Crs). Twenty-one infants with RDS after preterm birth received surfactant treatment. Six of them developed CLDN. Eighteen preterm infants without RDS served as a control group. Lung function measurements were performed at term age and 4, 8, and 12 months afterwards. FRC was obtained by means of the closed-system helium dilution technique whereas static Crs was obtained by means of the weighted spirometer technique. At term age, FRC was lower in the CLDN group compared with uncomplicated RDS and controls (p < 0.05). No significant differences between groups were found in the development of FRC during the first year of life (p = 0.4). No differences were found in Crs during the first year of life in surfactant treated infants who recovered from uncomplicated RDS and the control group. However, lower values were found in the CLDN group (p < 0.05). We conclude that surfactant treated infants without CLDN have similar lung development during the first year of life as control preterm infants.
KEYWORD
Prematurity - surfactant - lung function testing
REFERENCES
- 1 Myers M G, McGuinness A, Lachenbruch P A, Koontz F P, Hollingshead R, Olson D B. Respiratory illnesses in survivors of infant respiratory distress syndrome. Am Rev Respir Dis . 1986; 133 1011-1018
- 2 Bryan M H, Hardie M J, Reilly B J, Swyer P R. Pulmonary function studies during the first year of life in infants recovering from the respiratory distress syndrome. Pediatrics . 1973; 52 169-178
- 3 Stocks J, Godfrey S. The role of artificial ventilation, O2 and C.P.A.P. in the pathogenesis of lung damage in neonates, assessed by serial measurements of lung function. Pediatrics . 1976; 57 352-362
- 4 Wong Y C, Beardsmore C S, Silverman M. Pulmonary sequelae of neonatal respiratory distress in very low birthweight infnats: a clinical and physiological study. Arch Dis Child . 1982; 57 418-424
- 5 Yuksel B, Greenough A, Green S. Lung function abnormalities at 6 months of age after neonatal intensive care. Arch Dis Childh . 1991; 66 472-476
- 6 Yuksel B, Greenough A. Neonatal respiratory distress and lung function at follow-up. Respir Med . 1991; 85 235-237
- 7 Bhutani V K, Abbasi S, Long W A, Gerdes J S. Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant. J Pediatr . 1992; 120 S18-S24
- 8 Kelly E, Bryan H, Possmayer F, Frndova H, Bryan C. Compliance of the respiratory system in newborn infants pre- and postsurfactant replacement therapy. Pediatr Pulmonol . 1993; 15 225-230
- 9 Baraldi E, Pettenazzo A, Filippone M, Magagnin P, Saia O S, Zachello F. Rapid improvement of static compliance after surfactant treatment in preterm infants with respiratory distress syndrome. Pediatr Pulmonol . 1993; 15 157-162
- 10 de Winter P J, Merth I T, Van Bel F, Egberts J, Brand R, Quanjer P hH. Changes of respiratory system mechanics in ventilated lungs of preterm infants with two different schedules of surfactant treatment. Pediatr Res . 1994; 35 541-549
- 11 Soll R F, McQueen M C. Respiratory distress syndrome. In: Sinclair JC, Bracken MB, eds. Effective Care of the Newborn Infants Oxford: Oxford University Press 1992: 325-359
- 12 Walti H, Boulé M, Moriette G, Relier J. Pulmonary functional outcome at one year of age in infants treated with natural porcine surfactant at birth. Biol Neonate . 1992; 61(Suppl 1) 48-53
- 13 Couser R J, Ferrara T B, Wheeler W. Pulmonary follow-up 2.5 years after a randomized, controlled, multiple dose bovine surfactant study of preterm newborn infants. Pediatr Pulmonol . 1993; 15 163-167
- 14 Giedion A, Haefliger H, Dangel P. Acute pulmonary X-ray changes in hyaline membrane disease treated with artificial ventilation and positive end-expiratory pressure. Pediatr Radiol . 1973; 1 145-152
- 15 Toce S S, Farrell P M, Leavitt L A, Edwards D K. Clinical and roentgenographic scoring system for assessing bronchopulmonary dysplasia. Am J Dis Child . 1984; 138 581-585
- 16 Shennan A T, Dunn M S, Ohlsson A, Lennox K, Hoskins E M. Abnormal pulmonary outcome in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics . 1988; 82 527-532
- 17 Merth I T, Quanjer P hH, Verschragen G J. Functional residual capacity by the helium dilution method. In: Dezateux CA, Fletcher ME, Rabbette PS, Stanger LJ, Stocks J, eds. A Manual of Infant Lung Function Testing London 1991: 61-82
- 18 Merth I T, Verschragen G J, Olievier I CW, de Winter P J, Quanjer P hH. Water-sealed spirometer for measurements in newborns and infants. J Appl Physiol . 1993; 74 470-475
- 19 Cherniack R M, Brown E. A simple method for measuring total respiratory compliance: normal values for males. J Appl Physiol . 1965; 20 87-91
- 20 Merth I T, Quanjer P hH. Respiratory system compliance assessed by the multiple occlusion and weighted spirometer method in non-intubated healthy newborns. Pediatr Pulmonol . 1990; 8 273-279
- 21 Goldman S L, Bosque E, McCann E, Lewis K. Pulmonary mechanics in premature infants one month after treatment with synthetic surfactant. J Pediatr . 1992; 120 S25-S28
- 22 Ware J, Taeusch H W, Soll R F, McCormick M C. Health and developmental outcomes of a surfactant controlled trial: follow-up at 2 years. Pediatrics . 1990; 85 1103-1107
- 23 Vaucher Y E, Merritt T A, Hallman M, Jarvenpaa A-L, Telsey A M, Jone B L. Neurodevelopmental and respiratory outcome in early childhood after human surfactant treatment. Am J Dis Child . 1988; 142 927-930
- 24 Gerhardt T, Bancalari E. Chest wall compliance in full-term and premature infants. Acta Paediatr Scand . 1980; 69 359-364
- 25 Merth I T, de Winter P J, Borsboom G J M J, Quanjer P hH. Pulmonary function during the first year of life in healthy infants born prematurely. Eur Resp J . 1995; 8 1141-1147
- 26 LeSouëf P N, Lopes J M, England S J, Bryan M H, Bryan C. Influence of chest wall distortion on esophageal pressure. J Appl Physiol . 1983; 55 353-358
- 27 European Respiratory Society/American Respiratory Society. Respiratory mechanics in infants: physiologic evaluation in health and disease. Eur Respir J . 1993; 6 279-310
- 28 Silva Neto G, Gerhardt T O, Claure N, Duara S, Bancalari E. Influence of chestwall distortion and esophageal catheter position on esophageal manometry in preterm infants. Pediatr Res . 1995; 37 617-622
- 29 Pelkonen A S, Hakulinen A L, Turpeinen M, Hallman M. Effect of neonatal surfactant therapy on lung function at school age in children born very preterm. Pediatr Pulmonol . 1998; 25 182-190
- 30 Watts J L, Ariagno R L, Brady J P. Chronic pulmonary disease in neonates after artificial ventilation: distribution of ventilation and pulmonary interstitial emphysema. Pediatrics . 1977; 60 273-281
- 31 Tepper R S, Morgan W J, Coat K, Tausig L M. Expiratory flow limitation in infants with bronchopulmonary dysplasia. J Pediatr . 1986; 109 1040-1046
- 32 Greenspan J S, Abbasi S, Bhutani V K. Sequential changes in pulmonary mechanics in the very low birth weight (# 1000 grams) infant. J Pediatr . 1988; 113 732-737